EQL Pharma
Storberget
About EQL Pharma
EQL Pharma is a pharmaceutical company focused on efficiently and thoughtfully developing and marketing generic drugs in therapies and markets where the company sees strong potential for profitable growth. These may be markets where generic competition is weak or even lacking. It can also be a new formulation aimed at a specific therapy need or patient group. The possibilities are many and EQL sees no need to limit itself to either specific therapy areas, product groups, or geographies in the long run. EQL is strategically located in Lund with access to all the resources of organizations, companies, and individuals provided in the life science cluster called Medicon Valley. The company has built up a strong network of partners both in the cluster and in the rest of Europe and the world. A network that is in constant growth and refinement as new ideas and opportunities take shape. The company's goal is strong, but sustainable and profitable, growth. Robust financing and well-thought-out analyzes are behind every investment the company makes both in its pipeline and in its expansion into new markets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $31.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jan 2025)
- Ticker: fra:7JK
- Website: eqlpharma.com
- Phone: +46 046 12 01 70
Industries & Categories
Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eql-pharma-90090 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.